Review
doi: 10.1016/j.clim.2011.09.002.
Epub 2011 Sep 17.
The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player
Affiliations
- PMID: 21996455
- DOI: 10.1016/j.clim.2011.09.002
Item in Clipboard
Review
The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player
Clin Immunol.
2011 Dec.
Abstract
Functional naïve T-cells are critical for an effective immune response to multiple pathogens. HIV leads to a significant reduction in CD4+ naïve T-cell number and impaired function and there is incomplete recovery following combination antiretroviral therapy (cART). Here we review the basic homeostatic mechanisms that maintain naïve CD4+ T-cells and discuss recent developments in understanding the impact of HIV infection on naïve CD4+ T-cells. Finally we review therapeutic interventions in HIV-infected individuals aimed at specifically enhancing recovery of naïve CD4+ T-cells.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.Eur Cytokine Netw. 2004 Oct-Dec;15(4):279-89. Eur Cytokine Netw. 2004. PMID: 15627636 Review.
-
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.AIDS. 2006 Aug 22;20(13):1727-36. doi: 10.1097/01.aids.0000242819.72839.db. AIDS. 2006. PMID: 16931937
-
Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.Scand J Immunol. 2011 Mar;73(3):256-65. doi: 10.1111/j.1365-3083.2010.02502.x. Scand J Immunol. 2011. PMID: 21204901
-
Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.J Virol. 2006 Oct;80(20):10229-36. doi: 10.1128/JVI.00965-06. J Virol. 2006. PMID: 17005700 Free PMC article.
-
The value of preserving HIV-specific immune responses.J HIV Ther. 2003 Feb;8(1):19-25. J HIV Ther. 2003. PMID: 12840711 Review.
Cited by
-
Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie.For Immunopathol Dis Therap. 2015;6(1-2):67-77. doi: 10.1615/ForumImmunDisTher.2016014160. For Immunopathol Dis Therap. 2015. PMID: 28344852 Free PMC article.
-
Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.BMC Res Notes. 2017 Jun 8;10(1):197. doi: 10.1186/s13104-017-2521-0. BMC Res Notes. 2017. PMID: 28595630 Free PMC article.
-
Immune activation is associated with decreased thymic function in asymptomatic, untreated HIV-infected individuals.South Afr J HIV Med. 2016 Jul 28;17(1):445. doi: 10.4102/sajhivmed.v17i1.445. eCollection 2016. South Afr J HIV Med. 2016. PMID: 29568606 Free PMC article.
-
Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.AIDS Res Treat. 2012;2012:161584. doi: 10.1155/2012/161584. Epub 2012 May 27. AIDS Res Treat. 2012. PMID: 22693657 Free PMC article.
-
Host-Viral Interactions at the Maternal-Fetal Interface. What We Know and What We Need to Know.Frontiers (Boulder). 2022 Mar;2:833106. doi: 10.3389/fviro.2022.833106. Epub 2022 Mar 24. Frontiers (Boulder). 2022. PMID: 36742289 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
